2022 |
10/26 | 3,075 | 3,105 | 3,070 | 3,085 | +0.65% | 757,600 | 9154億3981万 | -2.34% |
10/25 | 3,050 | 3,075 | 3,020 | 3,065 | +0.99% | 1,223,600 | 9095億503万 | -3.13% |
10/24 | 3,100 | 3,105 | 3,025 | 3,035 | -1.94% | 1,247,600 | 9006億286万 | -4.17% |
10/21 | 3,120 | 3,135 | 3,085 | 3,095 | -0.96% | 1,050,600 | 9184億720万 | -2.43% |
10/20 | 3,135 | 3,145 | 3,125 | 3,125 | -0.48% | 1,017,000 | 9273億937万 | -1.67% |
10/19 | 3,150 | 3,165 | 3,135 | 3,140 | +0.16% | 858,400 | 9317億6046万 | -1.35% |
10/18 | 3,160 | 3,165 | 3,135 | 3,135 | -0.79% | 1,319,000 | 9302億7676万 | -1.63% |
10/17 | 3,185 | 3,185 | 3,150 | 3,160 | -0.63% | 942,600 | 9376億9524万 | -0.97% |
10/14 | 3,150 | 3,195 | 3,150 | 3,180 | +0.79% | 1,020,000 | 9436億3002万 | -0.38% |
10/13 | 3,160 | 3,170 | 3,140 | 3,155 | -0.79% | 809,600 | 9362億1154万 | -1.28% |
10/12 | 3,160 | 3,195 | 3,145 | 3,180 | +1.11% | 888,200 | 9436億3002万 | -0.66% |
10/11 | 3,145 | 3,165 | 3,135 | 3,145 | -0.32% | 915,600 | 9332億4415万 | -1.9% |
10/07 | 3,145 | 3,160 | 3,135 | 3,155 | -1.1% | 829,000 | 9362億1154万 | -1.77% |
10/06 | 3,235 | 3,235 | 3,190 | 3,190 | -0.78% | 787,200 | 9465億9741万 | -0.9% |
10/05 | 3,225 | 3,240 | 3,205 | 3,215 | -0.62% | 750,600 | 9540億1588万 | -0.28% |
10/04 | 3,190 | 3,240 | 3,185 | 3,235 | +2.54% | 968,400 | 9599億5066万 | +0.22% |
10/03 | 10:00 経済産業省「ワクチン生産体制強化のためのバイオ医薬品製造拠点等整備事業」公募採択に関するお知らせ |
10/03 | 3,195 | 3,200 | 3,145 | 3,155 | -1.87% | 994,800 | 9362億1154万 | -2.35% |
09/30 | 3,235 | 3,235 | 3,205 | 3,215 | +0.31% | 1,298,600 | 9540億1588万 | -0.71% |
09/29 | 3,140 | 3,210 | 3,125 | 3,205 | +0.16% | 1,117,800 | 9510億4849万 | -1.17% |
09/28 | 3,165 | 3,205 | 3,165 | 3,200 | -0.16% | 1,540,600 | 9495億6480万 | -1.54% |
09/27 | 3,165 | 3,215 | 3,160 | 3,205 | +1.42% | 1,232,800 | 9510億4849万 | -1.63% |
09/26 | 3,150 | 3,185 | 3,140 | 3,160 | -0.16% | 965,800 | 9376億9524万 | -3.22% |
09/22 | 3,190 | 3,190 | 3,165 | 3,165 | 0% | 750,600 | 9391億7893万 | -3.36% |
09/21 | 3,185 | 3,195 | 3,165 | 3,165 | -1.71% | 906,000 | 9391億7893万 | -3.65% |
09/20 | 3,190 | 3,220 | 3,185 | 3,220 | +0.94% | 828,000 | 9554億9958万 | -2.31% |
09/16 | 3,160 | 3,200 | 3,160 | 3,190 | +0.95% | 880,800 | 9465億9741万 | -3.45% |
09/15 | 3,160 | 3,175 | 3,150 | 3,160 | 0% | 761,600 | 9376億9524万 | -4.62% |
09/14 | 3,200 | 3,200 | 3,150 | 3,160 | -2.17% | 1,747,400 | 9376億9524万 | -4.93% |
09/13 | 3,235 | 3,265 | 3,210 | 3,230 | -1.07% | 1,636,600 | 9584億6697万 | -3.09% |
09/12 | 3,250 | 3,275 | 3,235 | 3,265 | +0.93% | 641,400 | 9688億5283万 | -2.22% |
09/09 | 3,215 | 3,245 | 3,215 | 3,235 | -0.15% | 1,016,200 | 9599億5066万 | -3.23% |
09/08 | 3,205 | 3,260 | 3,205 | 3,240 | +1.73% | 974,400 | 9614億3436万 | -3.23% |
09/07 | 3,245 | 3,270 | 3,180 | 3,185 | -2.3% | 1,185,800 | 9451億1371万 | -5.07% |
09/06 | 3,285 | 3,305 | 3,250 | 3,260 | -0.76% | 1,128,400 | 9673億6914万 | -3.12% |
09/05 | 3,285 | 3,305 | 3,280 | 3,285 | -0.76% | 632,400 | 9747億8761万 | -2.64% |
09/02 | 3,315 | 3,325 | 3,295 | 3,310 | +0.15% | 692,200 | 9822億609万 | -2.13% |
09/01 | 3,300 | 3,315 | 3,285 | 3,305 | -0.3% | 843,800 | 9807億2239万 | -2.48% |
08/31 | 3,300 | 3,320 | 3,285 | 3,315 | -0.15% | 2,125,600 | 9836億8978万 | -2.41% |
08/30 | 3,315 | 3,330 | 3,305 | 3,320 | +0.45% | 461,600 | 9851億7348万 | -2.47% |
08/29 | 3,300 | 3,325 | 3,280 | 3,305 | -0.3% | 911,800 | 9807億2239万 | -3.14% |
08/26 | 3,345 | 3,350 | 3,315 | 3,315 | -0.6% | 776,200 | 9836億8978万 | -2.99% |
08/25 | 15:00 新型コロナウイルス感染症に対するレプリコンワクチン「ARCT-154」の製造販売に関する協議についてのお知らせ |
08/25 | 3,345 | 3,350 | 3,325 | 3,335 | -0.15% | 678,200 | 9896億2456万 | -2.51% |
08/24 | 3,350 | 3,365 | 3,330 | 3,340 | -1.04% | 919,600 | 9911億826万 | -2.4% |
08/23 | 3,405 | 3,405 | 3,370 | 3,375 | -0.59% | 875,000 | 1兆14億 | -1.4% |
08/22 | 3,385 | 3,400 | 3,345 | 3,395 | +0.3% | 832,200 | 1兆74億 | -0.88% |
08/19 | 3,390 | 3,405 | 3,370 | 3,385 | -0.59% | 573,200 | 1兆44億 | -1.2% |
08/18 | 3,460 | 3,460 | 3,405 | 3,405 | -0.58% | 726,800 | 1兆103億 | -0.76% |
08/17 | 3,440 | 3,440 | 3,410 | 3,425 | -0.15% | 779,000 | 1兆163億 | -0.32% |
08/16 | 3,455 | 3,455 | 3,405 | 3,430 | +0.15% | 646,000 | 1兆178億 | -0.29% |
08/15 | 3,400 | 3,430 | 3,375 | 3,425 | 0% | 1,268,000 | 1兆163億 | -0.52% |
08/12 | 3,450 | 3,475 | 3,405 | 3,425 | -0.44% | 1,444,400 | 1兆163億 | -0.67% |
08/10 | 3,380 | 3,455 | 3,345 | 3,440 | +2.08% | 1,797,200 | 1兆207億 | -0.26% |
08/09 | 14:00 2023年3月期第1四半期決算短信〔日本基準〕(連結) |
08/09 | 3,395 | 3,410 | 3,275 | 3,370 | -0.3% | 2,201,400 | 1兆1043万 | -2.26% |
08/08 | 15:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
08/08 | 3,380 | 3,390 | 3,365 | 3,380 | 0% | 726,200 | 1兆29億 | -2.03% |
08/05 | 3,355 | 3,395 | 3,355 | 3,380 | +0.75% | 765,200 | 1兆29億 | -1.97% |
08/04 | 3,445 | 3,450 | 3,345 | 3,355 | -1.32% | 1,171,600 | 9955億5934万 | -2.64% |
08/03 | 16:00 乾燥細胞培養痘そうワクチンLC16「KMB」の「サル痘の予防」に関する効能・効果の追加承認取得に関するお知らせ |
08/03 | 3,465 | 3,465 | 3,390 | 3,400 | -1.31% | 819,200 | 1兆89億 | -1.31% |
08/02 | 3,490 | 3,490 | 3,410 | 3,445 | -1.43% | 867,400 | 1兆222億 | +0.09% |
08/01 | 3,450 | 3,500 | 3,440 | 3,495 | +0.58% | 785,800 | 1兆371億 | +1.72% |
07/29 | 3,480 | 3,495 | 3,460 | 3,475 | -0.29% | 956,400 | 1兆311億 | +1.34% |
07/28 | 3,505 | 3,520 | 3,475 | 3,485 | -0.57% | 1,035,800 | 1兆341億 | +1.87% |
07/27 | 3,500 | 3,525 | 3,490 | 3,505 | +0.57% | 979,200 | 1兆400億 | +2.76% |
07/26 | 3,540 | 3,555 | 3,470 | 3,485 | -0.99% | 1,204,200 | 1兆341億 | +2.53% |
07/25 | 3,485 | 3,565 | 3,480 | 3,520 | +2.47% | 2,162,800 | 1兆445億 | +3.93% |
07/22 | 3,435 | 3,450 | 3,420 | 3,435 | +0.59% | 839,800 | 1兆192億 | +1.75% |
07/21 | 3,355 | 3,420 | 3,350 | 3,415 | +1.34% | 971,800 | 1兆133億 | +1.55% |
07/20 | 3,370 | 3,385 | 3,350 | 3,370 | +0.15% | 1,035,000 | 1兆1043万 | +0.57% |
07/19 | 3,390 | 3,400 | 3,325 | 3,365 | -1.17% | 935,800 | 9985億2673万 | +0.72% |
07/15 | 3,440 | 3,450 | 3,340 | 3,405 | -0.87% | 1,564,200 | 1兆103億 | +2.16% |
07/14 | 3,475 | 3,480 | 3,420 | 3,435 | -1.72% | 1,449,800 | 1兆192億 | +3.43% |
07/13 | 3,520 | 3,525 | 3,485 | 3,495 | -0.99% | 875,800 | 1兆371億 | +5.62% |
07/12 | 3,545 | 3,545 | 3,505 | 3,530 | 0% | 772,400 | 1兆474億 | +7.1% |
07/11 | 15:30 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
07/11 | 3,460 | 3,535 | 3,455 | 3,530 | +0.71% | 1,239,600 | 1兆474億 | +7.59% |
07/08 | 3,530 | 3,535 | 3,465 | 3,505 | -1.41% | 1,517,000 | 1兆400億 | +7.28% |
07/07 | 3,500 | 3,555 | 3,480 | 3,555 | +3.04% | 1,769,400 | 1兆549億 | +9.25% |
07/06 | 10:15 新型コロナウイルス感染症(COVID-19)に対するワクチンKD-414の第2⁄3相臨床試験の結果概要に関するお知らせ |
07/06 | 3,405 | 3,460 | 3,400 | 3,450 | +1.32% | 1,451,400 | 1兆237億 | +6.55% |
07/05 | 3,425 | 3,435 | 3,405 | 3,405 | -0.44% | 676,200 | 1兆103億 | +5.45% |
07/04 | 3,380 | 3,425 | 3,360 | 3,420 | +2.7% | 1,149,600 | 1兆148億 | +6.21% |
07/01 | 3,350 | 3,375 | 3,320 | 3,330 | 0% | 774,200 | 9881億4087万 | +3.67% |
06/30 | 3,350 | 3,370 | 3,320 | 3,330 | -0.3% | 1,201,000 | 9881億4087万 | +3.9% |
06/29 | 3,325 | 3,370 | 3,300 | 3,340 | +0.3% | 2,189,200 | 9911億826万 | +4.34% |
06/28 | 3,305 | 3,330 | 3,285 | 3,330 | +1.06% | 745,600 | 9881億4087万 | +4.16% |
06/27 | 3,305 | 3,320 | 3,270 | 3,295 | -0.3% | 692,600 | 9777億5500万 | +3.16% |
06/24 | 3,285 | 3,310 | 3,265 | 3,305 | +0.61% | 1,012,000 | 9807億2239万 | +3.51% |
06/23 | 3,235 | 3,295 | 3,235 | 3,285 | +1.23% | 1,001,000 | 9747億8761万 | +2.95% |
06/22 | 3,205 | 3,260 | 3,190 | 3,245 | +1.56% | 1,129,200 | 9629億1805万 | +1.69% |
06/21 | 3,205 | 3,230 | 3,180 | 3,195 | 0% | 900,200 | 9480億8110万 | +0.09% |
06/20 | 3,250 | 3,250 | 3,180 | 3,195 | -0.93% | 830,600 | 9480億8110万 | -0.03% |
06/17 | 3,125 | 3,230 | 3,110 | 3,225 | +3.04% | 3,054,000 | 9569億8327万 | +0.75% |
06/16 | 3,100 | 3,135 | 3,090 | 3,130 | +0.81% | 1,029,400 | 9287億9307万 | -2.34% |
06/15 | 15:00 投資単位の引下げに関する考え方および方針等について |
06/15 | 3,115 | 3,135 | 3,105 | 3,105 | -0.32% | 902,400 | 9213億7459万 | -3.3% |
06/14 | 3,120 | 3,145 | 3,105 | 3,115 | -1.42% | 891,600 | 9243億4198万 | -3.23% |
06/13 | 3,115 | 3,175 | 3,115 | 3,160 | +1.44% | 955,800 | 9376億9524万 | -2.02% |
06/10 | 3,135 | 3,145 | 3,110 | 3,115 | -0.95% | 1,156,800 | 9243億4198万 | -3.47% |
06/09 | 3,175 | 3,185 | 3,145 | 3,145 | -0.63% | 962,400 | 9332億4415万 | -2.75% |
06/08 | 3,165 | 3,185 | 3,160 | 3,165 | +0.16% | 867,600 | 9391億7893万 | -2.28% |
06/07 | 3,165 | 3,195 | 3,145 | 3,160 | -0.16% | 999,600 | 9376億9524万 | -2.53% |
06/06 | 3,165 | 3,180 | 3,155 | 3,165 | -0.47% | 729,400 | 9391億7893万 | -2.38% |
06/03 | 3,170 | 3,195 | 3,170 | 3,180 | +0.32% | 755,200 | 9436億3002万 | -1.97% |
06/02 | 3,195 | 3,205 | 3,170 | 3,170 | -1.4% | 518,000 | 9406億6263万 | -2.31% |